Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary thrombocythemia: diagnosis, clinical manifestations and management.

Literature DB >> 8347730

Primary thrombocythemia: diagnosis, clinical manifestations and management.

P J van Genderen¹, J J Michiels.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1993 PMID： 8347730 DOI： 10.1007/bf01788127

Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673

× No keyword cloud information.

57 in total

1. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Authors: S Murphy; H Iland; D Rosenthal; J Laszlo
Journal: Semin Hematol Date: 1986-07 Impact factor: 3.851

2. Treatment of essential thrombocythaemia by alpha 2a interferon.

Authors: S Bellucci; J L Harousseau; P Brice; G Tobelem
Journal: Lancet Date: 1988-10-22 Impact factor: 79.321

3. Alpha-interferon therapy for essential thrombocythaemia.

Authors: F J Giles; C R Singer; A G Gray; K L Yong; M Brozovic; S C Davies; I R Grant; A V Hoffbrand; S J Machin; A B Mehta
Journal: Lancet Date: 1988-07-09 Impact factor: 79.321

4. Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea.

Authors: E Löfvenberg; A Wahlin
Journal: Eur J Haematol Date: 1988-10 Impact factor: 2.997

Review 5. Primary thrombocythaemia: diagnosis and management.

Authors: T C Pearson
Journal: Br J Haematol Date: 1991-06 Impact factor: 6.998

6. Erythromelalgia in thrombocythemia of various myeloproliferative disorders.

Authors: J J Michiels; F J ten Kate
Journal: Am J Hematol Date: 1992-02 Impact factor: 10.047

7. Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients.

Authors: M Colombi; F Radaelli; L Zocchi; A T Maiolo
Journal: Cancer Date: 1991-06-01 Impact factor: 6.860

8. Histopathology of erythromelalgia in thrombocythaemia.

Authors: J J Michiels; F W ten Kate; V D Vuzevski; J Abels
Journal: Histopathology Date: 1984-07 Impact factor: 5.087

9. Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients.

Authors: A Grossi; S Rosseti; A M Vannucchi; D Rafanelli; P R Ferrini
Journal: Clin Lab Haematol Date: 1988

Review 10. Chronic myeloproliferative disorders (CMPD).

Authors: R Burkhardt; R Bartl; K Jäger; B Frisch; G Kettner; G Mahl; M Sund
Journal: Pathol Res Pract Date: 1984-11 Impact factor: 3.250

7 in total

1. Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatment.

Authors: N Evangelou; T Littlewood; P Anslow; H Chapel
Journal: J Clin Pathol Date: 2003-04 Impact factor: 3.411

7. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.

Authors: P J van Genderen; J J Michiels; S C van der Poel-van de Luytgaarde; H H van Vliet
Journal: Ann Hematol Date: 1994-08 Impact factor: 3.673